%0 Journal Article
%T BRAFV600E
vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
%A Hongyan Deng
%A Jianxiang Wang
%A Meiping Shen
%A Qing Yao
%A Ting Xu
%A Xiao Li
%A Xiaohong Wu
%A Xin Zhao
%A Xingyue Cao
%A Xinhua Ye
%A Ya Wu
%J Archive of "Cancer Biology & Medicine".
%D 2019
%R 10.20892/j.issn.2095-3941.2018.0291
%X Bethesda System for Reporting Thyroid Cytopathology (BSRTC) categories I, III, and V account for a significant proportion of fine needle aspiration cytology (FNAC) diagnoses. This study aimed to compare the diagnostic efficacy of BRAFV600E mutation and the Thyroid Imaging Reporting and Data System (TIRADS) classification in differentiating papillary thyroid cancers (PTCs) from benign lesions among BSRTC I, III, and V nodules
%K Papillary thyroid carcinoma
%K fine-needle aspiration cytology (FNAC)
%K BRAFV600E
%K thyroid imaging reporting and data system (TIRADS)
%K Bethesda classification
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528444/